Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
25.00
+0.16 (0.64%)
At close: Sep 17, 2025, 4:00 PM EDT
25.17
+0.17 (0.68%)
After-hours: Sep 17, 2025, 7:59 PM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $9.73 billion as of September 17, 2025. Its market cap has decreased by -67.39% in one year.
Market Cap
9.73B
Enterprise Value
2.96B
1-Year Change
-67.39%
Ranking
Category
Stock Price
$25.00
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $9.73B, an increase of 58.98%. That is a compound annual growth rate of 7.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 9.66B | -39.60% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | 41.34B | 534.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |